Organogenesis Holdings Stock Performance
| ORGO Stock | USD 2.79 0.06 2.11% |
The company holds a Beta of 2.0, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Organogenesis Holdings will likely underperform. Organogenesis Holdings has an expected return of -0.12%. Please make sure to check Organogenesis Holdings standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and rate of daily change , to decide if Organogenesis Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Organogenesis Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (4.04) | Five Day Return 13.55 | Year To Date Return (30.15) | Ten Year Return (70.77) | All Time Return (70.77) |
1 | Acquisition by David Francisco of 160350 shares of Organogenesis Holdings subject to Rule 16b-3 | 02/23/2024 |
2 | Organogenesis Holdings stock falls 16 percent in past week as three-year earnings and shareholder returns continue downward trend | 03/04/2024 |
3 | Disposition of 152250 shares by Patrick Bilbo of Organogenesis Holdings at 1.18 subject to Rule 16b-3 | 03/28/2024 |
4 | Disposition of 10113 shares by Gillheeney Gary S. of Organogenesis Holdings at 2.8 subject to Rule 16b-3 | 04/01/2024 |
5 | Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case | 04/03/2024 |
6 | Organogenesis Holdings Inc.s Stock Has Been Sliding But Fundamentals Look Strong Is The ... - Yahoo Movies Canada | 04/11/2024 |
7 | Disposition of 103842 shares by Cavorsi Robert of Organogenesis Holdings at 3.43 subject to Rule 16b-3 | 04/19/2024 |
8 | Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis | 05/02/2024 |
9 | Organogenesis to Release Earnings on Thursday - Defense World | 05/07/2024 |
10 | Organogenesis Holdings Inc. Q1 2024 Earnings Call Transcript | 05/10/2024 |
| Begin Period Cash Flow | 103.3 M |
Organogenesis |
Organogenesis Holdings Relative Risk vs. Return Landscape
If you would invest 342.00 in Organogenesis Holdings on February 17, 2024 and sell it today you would lose (63.50) from holding Organogenesis Holdings or give up 18.57% of portfolio value over 90 days. Organogenesis Holdings is currently does not generate positive expected returns and assumes 6.4938% risk (volatility on return distribution) over the 90 days horizon. In different words, 57% of stocks are less volatile than Organogenesis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Organogenesis Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Organogenesis Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Organogenesis Holdings, and traders can use it to determine the average amount a Organogenesis Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0188
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ORGO |
Estimated Market Risk
| 6.49 actual daily | 57 57% of assets are less volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Organogenesis Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Organogenesis Holdings by adding Organogenesis Holdings to a well-diversified portfolio.
Organogenesis Holdings Fundamentals Growth
Organogenesis Stock prices reflect investors' perceptions of the future prospects and financial health of Organogenesis Holdings, and Organogenesis Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Organogenesis Stock performance.
| Return On Equity | 0.0215 | ||||
| Return On Asset | 0.0201 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 407.87 M | ||||
| Shares Outstanding | 132.57 M | ||||
| Price To Earning | 17.12 X | ||||
| Price To Book | 1.37 X | ||||
| Price To Sales | 0.88 X | ||||
| Revenue | 433.14 M | ||||
| Gross Profit | 345.87 M | ||||
| EBITDA | 39.77 M | ||||
| Net Income | 4.95 M | ||||
| Cash And Equivalents | 113.24 M | ||||
| Cash Per Share | 0.87 X | ||||
| Total Debt | 119.35 M | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 2.62 X | ||||
| Book Value Per Share | 2.10 X | ||||
| Cash Flow From Operations | 30.92 M | ||||
| Earnings Per Share | 0.04 X | ||||
| Market Capitalization | 377.83 M | ||||
| Total Asset | 460.02 M | ||||
| Retained Earnings | (40.97 M) | ||||
| Working Capital | 144.53 M | ||||
| Current Asset | 24.47 M | ||||
| Current Liabilities | 23.22 M | ||||
About Organogenesis Holdings Performance
To evaluate Organogenesis Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Organogenesis Holdings generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Organogenesis Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Organogenesis Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Organogenesis's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 83.60 | 100.23 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.04 | 0.05 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.02 | 0.02 |
Things to note about Organogenesis Holdings performance evaluation
Checking the ongoing alerts about Organogenesis Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Organogenesis Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Organogenesis Holdings generated a negative expected return over the last 90 days | |
| Organogenesis Holdings has high historical volatility and very poor performance | |
| About 33.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Organogenesis Holdings Inc. Q1 2024 Earnings Call Transcript |
- Analyzing Organogenesis Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Organogenesis Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Organogenesis Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Organogenesis Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Organogenesis Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Organogenesis Holdings' stock. These opinions can provide insight into Organogenesis Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Organogenesis Stock analysis
When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.307 | Earnings Share 0.04 | Revenue Per Share 3.313 | Quarterly Revenue Growth 0.022 | Return On Assets 0.0201 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.